Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 5Unknown 2Terminated 2Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1NET 1Endocrine 1

Conditions

Respiratory Insufficiency 1Radiation Pneumonitis 1Neuroendocrine Tumors 1Lung Neoplasms 1Lung Diseases 1Abnormalities, Radiation-Induced 1

Interventions

pembrolizumab 562Specimen Handling 490Carboplatin 451Magnetic Resonance Spectroscopy 444Cyclophosphamide 418Cisplatin 406Radiotherapy 353Gemcitabine 314Bevacizumab 313Paclitaxel 298Biopsy 290Drug Therapy 283Blood Specimen Collection 248Capecitabine 245Oxaliplatin 241fludarabine 240Nivolumab 234venetoclax 221Injections 213Docetaxel 211Fluorouracil 205Dexamethasone 187Radiosurgery 182Rituximab 159Standard of Care 158Pemetrexed 156Surgical Procedures, Operative 148durvalumab 145atezolizumab 145Leucovorin 139

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Tomography, Emission-Computed, Single-Photon × Clear all
NCT06122610 2026-05-15

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

University of Wisconsin, Madison

Phase 1 Recruiting
10 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT04676828 2026-02-24

ASPECT

University of Aarhus

Phase NA Recruiting
90 enrolled
Thoracic

Abnormalities, Radiation-Induced, Lung Diseases, Lung Neoplasms, Respiratory Insufficiency, Radiation Pneumonitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡